By IDSE News Staff
The FDA issued an emergency use authorization (EUA) for the modified vaccinia Ankara vaccine (MVA; Jynneos, Bavarian Nordic) to allow healthcare providers to use the vaccine by intradermal injection for people who are 18 years of age and older who are determined to be at high risk for monkeypox infection. This will increase the amount of vaccine because intradermal injections require a smaller dose than subcutaneous injections, the agency said.
As of Aug. 9, there were